Press release
Exploring the Sizable Growth of the Global Clinical Biomarkers Market: Influences, Key Players, and Forecast Until 2029
Clinical Biomarkers Market Size
• The clinical biomarkers market size has grown in recent years and will expand from $30.78 billion in 2024 to $33.85 billion in 2025, representing a compound annual growth rate (CAGR) of 10.0%.
• Primary causes for growth in the historic period include increased prevalence of chronic disease, focus on personalized medicine and targeted therapies, and support from regulatory bodies.
• The market is predicted to surge to $52.8 billion in 2029 at a CAGR of 11.8%. The key drivers for this forecasted large increase are the continued development of companion diagnostics, heightened focus on early diagnosis and disease prevention, along with the expanding applications in precision oncology and neurodegenerative diseases, and infectious disease control.
High Cancer Prevalence: What Is Its Impact on the Growth of the Clinical Biomarkers Market?
The high cancer prevalence is a major factor propelling the growth of the clinical biomarker market. Cancer, defined as abnormal cell growth, poses significant threats to health and wellbeing. Clinical biomarkers play an instrumental role in preventing cancer through aiding early detection, risk assessment, and monitoring individuals at high risk. For instance, Cancer Research UK predicts an increase in new kidney cancer cases from roughly 16,300 to about 21,900 by 2038-2040, indicating a 15% increase in this period. Such trends underscore the role of high cancer prevalence in spurring the clinical biomarker market growth.
Request A Free Sample Copy here: https://www.thebusinessresearchcompany.com/sample.aspx?id=12670&type=smp
Who Are the Key Players Driving Clinical Biomarkers Market Growth?
Prominent companies operating in the clinical biomarkers market include:
• Johnson and Johnson Services Inc.
• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Danaher Corporation
• Merck KGaA
• Becton Dickinson and Company
• Eurofins Scientific
• Agilent Technologies Inc.
• Epigenomics AG
• Grifols S.A.
• Illumina Inc.
• BioMerieux SA.
• Charles River Laboratories International Inc.
• PerkinElmer Inc.
• Sartorius AG
• Sysmex Corporation
• Waters Corporation
• Bio-Rad Laboratories Inc.
• Bruker Corporation
• Qiagen N.V.
• Myriad Genetics Inc.
• Luminex Corporation
• Veracyte Inc.
• Centogene N.V.
• NanoString Technologies Inc.
• Enzo Biochem Inc.
• Biocartis Group NV
• Agendia Inc.
• Siemens Healthcare Private Limited
Key Trends in the Clinical Biomarkers Market: What Are They?
• AI-powered biomarker discovery
• Machine learning integration
• Multi-omics integration
• Technological innovations
• Partnerships between key players
What Are The Segments Of The Global Clinical Biomarkers Market?
The clinical biomarkers market is segmented by:
1) Offering: Product, Service
2) Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), Enzyme-Linked Immunosorbent Assay (ELISA), Other Technologies
3) Clinical Area: Cancer Biomarker, Cardiac Biomarker, Neurological Biomarker, Infectious Disease Biomarker, Immunological Biomarker, Non-Invasive Prenatal Testing, Other Clinical Areas
4) Application: Clinical Diagnostic, Translational Research
5) End User: Contract Research Organizations (CROs), Research And Academic Laboratories, Biopharmaceutical And Biotech Companies, Diagnostic Centers, Other End Users
Which Region is Dominating the Clinical Biomarkers Market?
In 2024, North America was the largest region in the clinical biomarkers market. Other regions covered in the clinical biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, South America, Middle East, and Africa.
Pre-book the Report for Swift Delivery here: https://www.thebusinessresearchcompany.com/report/clinical-biomarkers-global-market-report
What Is Covered In The Clinical Biomarkers Market Global Market Report?
- Market Size Analysis: Analyze the Clinical Biomarkers Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Clinical Biomarkers Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Clinical Biomarkers Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Clinical Biomarkers Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Request Customization for This Report here: https://www.thebusinessresearchcompany.com/customise?id=12670&type=smp
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Exploring the Sizable Growth of the Global Clinical Biomarkers Market: Influences, Key Players, and Forecast Until 2029 here
News-ID: 3833695 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Biomarker
Transformative Trends Impacting the Multiplex Biomarker Imaging Market Landscape …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Multiplex Biomarker Imaging Market Size By 2025?
In recent times, the size of the multiplex biomarker imaging market has experienced significant growth. There is an expected rise from $0.49 billion in 2024 to $0.54 billion in 2025, with a compound annual growth rate (CAGR) of…
Biomarker Discovery Outsourcing Services Market Biomarker Discovery Outsourcing: …
Biomarker Discovery Outsourcing Services Market to reach over USD 52.82 billion by the year 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biomarker Discovery Outsourcing Services Market Size, Share & Trends Analysis Report By Type (Predictive Biomarkers, Prognostic Biomarkers, Safety Biomarkers And Surrogate Endpoints),
Therapeutic Area (Oncology, Neurology, Cardiology, Autoimmune Diseases), Discovery Phase (Biomarker Identification, Biomarker Validation,…
Biomarker and Companion Diagnostics Conference | Modeling Strategies for Biomark …
MarketsandMarkets presents the Immunobio Series, an extraordinary set of conferences taking place on 20-21 June 2024 in Boston, USA.
Register Now @ https://events.marketsandmarkets.com/2nd-annual-biomarker-and-companion-diagnostics-conference-usa-edition/register
MarketsandMarkets 5th Annual Biomarker and Companion Diagnostics Conference:
Immerse yourself in the realm of biomarkers at our flagship event, where industry leaders and experts converge to propel innovation in healthcare, diagnostics, and personalized medicine. This conference serves as a dynamic platform for collaboration, knowledge sharing, and exploration of cutting-edge…
Biomarker Testing Market | Agilent Technologies, Roche, ,
The global biomarker testing market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the biomarker testing market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth of the…
Central Nervous System (CNS) Biomarkers Market Analysis Forecast 2023-2028 Globa …
The Central Nervous System (CNS) biomarkers market refers to the market for biomarkers used in the diagnosis, prognosis, and monitoring of diseases and disorders affecting the central nervous system. The central nervous system includes the brain and spinal cord, and disorders affecting this system can have significant impacts on an individual's health and well-being.
CNS biomarkers are measurable indicators that can provide information about the state of the central nervous system,…
Multiplex Biomarker Imaging Market - Advanced Solutions for Comprehensive Biomar …
Newark, New Castle, USA: The "Multiplex Biomarker Imaging Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Multiplex Biomarker Imaging Market: https://www.growthplusreports.com/report/multiplex-biomarker-imaging-market/8558
This latest report researches the industry structure,…
